Meiji Seika Kaisha, Ltd. And Solvay Seiyaku Obtain Additional Approval For Fluvoxamine Maleate 
10/19/2005 5:13:22 PM

Tokyo (JCN) Oct 14, 2005- Meiji Seika Kaisha and Solvay Seiyaku jointly announced on October 12 that they have obtained approval of additional indication for fluvoxamine maleate from the Ministry of Health, Labor and Welfare as of October 11. Fluvoxamine maleate is now available in the treatment of social-anxiety disorder.